Combination of brimonidine and timolol for topical ophthalmic use
US7320976B2 · kind B2 · utility
15Cited by
12References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 2003 |
| Grant date | Jan 22, 2008 |
| Priority date | — |
| Expiry date | Jun 15, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.